Skip to main content

Table 2 Univariate and multivariate analyses of different parameters for overall survival (OS) and distant metastasis-free survival (DMFS) of NPC patients

From: Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling

Variables

Univariate analysis

Multivariate analysis

HR

Cl

P

HR

Cl

P

OS

 Gender 

1.186

0.540–2.607

0.671

1.148

0.518–2.544

0.734

 Age 

2.875

1.308–6.319

0.009

3.219

1.444–7.176

0.004

 T stage 

1.697

0.647–4.454

0.282

1.218

0.413–3.592

0.721

 N stage 

1.689

0.812–3.513

0.161

1.653

0.738–3.703

0.222

 Clinical stage 

23.340

0.095–5718.732

0.262

0.00

0.000

0.975

 CLCA2 level

0.457

0.208–1.004

0.051

0.403

0.182–0.891

0.025

DMFS

 Gender 

0.940

0.339–2.611

0.906

0.879

0.313–2.469

0.807

 Age 

0.859

0.345–2.136

0.743

.868

0.341–2.210

0.767

 T stage 

1.280

0.425–3.858

0.661

1.651

0.489–5.569

0.419

 N stage 

2.860

1.087–7.527

0.033

3.069

1.084–8.691

0.035

 Clinical stage 

23.272

0.025–22,096.778

0.368

187,840.553

0.000

 

 CLCA2 level

0.343

0.123–0.952

0.040

0.317

0.113–0.890

0.0290

  1. Abbreviation: CI confidence interval, HR hazard ratio. Statistical significance (p <0.05) is shown in bold
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us